
About Bhojwani Universal Impex
Bhojwani Universal Impex is a Healthcare company based in Mumbai (India) by Jagdish Bhojwani. Bhojwani Universal Impex provides comprehensive solutions for pharmaceutical APIs. It operates on a B2B model. Its Indian entity Bhojwani Universal Impex Private Limited reported revenue of βΉ229 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Bhojwani Universal Impex bhojwani universal impex provides comprehensive solutions for pharmaceutical apis through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Founders Jagdish Bhojwani
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website bhojwanis.net
- Legal Name Bhojwani Universal Impex Private Limited
- Date of Incorporation 12 Mar, 2014
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹229 Cr
FY 2025 · +42% YoY
- Net Profit₹1.79 Cr
FY 2025 · 1% margin
- EBITDA₹9.83 Cr
FY 2025 · 4% margin
Associated legal entities of Bhojwani Universal Impex
Bhojwani Universal Impex operates through Bhojwani Universal Impex Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bhojwani Universal Impex Private Limited CIN U51101MH2014PTC254199 | Active | 12 Mar 2014 | Mumbai, Maharashtra | ₹229 Cr | 3 | View details |
Board of directors of Bhojwani Universal Impex Private Limited (Bhojwani Universal Impex)
Bhojwani Universal Impex Private Limited is the primary company behind Bhojwani Universal Impex. The board of Bhojwani Universal Impex Private Limited currently have 3 directors; the longest-serving is Jagdish Tuljaram Bhojwani, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jagdish Tuljaram Bhojwani DIN 01311671 | Director | 12 Mar 2014 | 12 yrs 7 mo | Bhojwani Universal Impex Private Limited |
| Vinisha Jagdish Bhojwani DIN 06565234 | Director | 12 Mar 2014 | 12 yrs 7 mo | Bhojwani Universal Impex Private Limited |
| Tuljaram Kauraram Bhojwani DIN 06884326 | Director | 20 May 2014 | 12 yrs 5 mo | Bhojwani Universal Impex Private Limited |
People of Bhojwani Universal Impex
1 people are tracked at Bhojwani Universal Impex (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for Bhojwani Universal Impex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bhojwani Universal Impex
Figures of Bhojwani Universal Impex Private Limited, the primary company behind Bhojwani Universal Impex, for FY 2025. Revenue was ₹229 Cr (+42% year on year). Net profit was ₹1.79 Cr (1% margin). EBITDA was ₹9.83 Cr (4% margin). Revenue has grown at a compounded annual rate of +14% over three years and +14% over five years.
- ₹229 CrRevenue · FY 2025 · +42% YoY
- ₹1.79 CrNet profit · 1% margin
- ₹9.83 CrEBITDA · 4% margin
- ₹1.00 CrPaid-up capital
- +14%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bhojwani Universal Impex Private Limited are on its company page.
Detailed financial statements for Bhojwani Universal Impex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Bhojwani Universal Impex
Bhojwani Universal Impex has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Bhojwani Universal Impex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bhojwani Universal Impex
Bhojwani Universal Impex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Bhojwani Universal Impex, Bhojwani Universal Impex Private Limited, reported revenue of βΉ229 Cr for FY 2025, up 42% year on year.
Bhojwani Universal Impex bhojwani universal impex provides comprehensive solutions for pharmaceutical apis through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Bhojwani Universal Impex's top competitors include Laurus Labs, Symbiotec and SeQuent.
Bhojwani Universal Impex operates through Bhojwani Universal Impex Private Limited.
The legal entities of Bhojwani Universal Impex currently have 3 directors, including Jagdish Tuljaram Bhojwani, Tuljaram Kauraram Bhojwani, Vinisha Jagdish Bhojwani.